COVID-19: Dr Reddy’s signs deal to make and sell favipiravir globally

Dr. Reddy’s Laboratories, one of India’s biggest pharmaceuticals manufacturers, said it has signed a licensing agreement with Japan-based FUJIFILM to manufacture anti-viral drug favipiravir. Favipiravir is traditionally used to treat infuenza, and is also being tested in COVID-19 patients. Dr Reddy’s said the tie-up is part of the Japanese company’s efforts to ramp up the […]

Dr Reddy’s sells two neurology products to Upsher-Smith Laboratories

Hyderabad-headquartered pharmaceutical firm Dr Reddy’s Laboratories said that it will sell two of its branded neurology products to US-based pharmaceutical company Upsher-Smith Laboratories. Dr Reddy’s will sell its US and select territory rights for  Zembrace Symtouch injection and Tosymra nasal spray to Upsher-Smith. Both drugs are sold through Dr Reddy’s wholly-owned subsidiary, Promius Pharma. Zembrace […]

Dr Reddy’s launches Daptomycin antibiotic in US

Pharmaceutical firm Dr Reddy’s Laboratories Ltd said it has launched Daptomycin antibiotic in the US market. Daptomycin is used alone or in combination with other medications to treat certain blood infections or serious skin infections caused by bacteria. It belongs to a class of medications called cyclic lipopeptide antibiotics. Daptomycin is marketed in the United […]

Dr Reddy’s Laboratories launches Testosterone Gel in the US

Hyderabad-headquartered Dr Reddy’s Laboratories said it has launched a therapeutic equivalent of AbbVie Inc’s AndroGel in the US market, a month after rival Lupin did so. Testosterone Gel is used for hormone replacement in men who are not able to produce enough testosterone. The medication is absorbed through the skin, enters the bloodstream, and helps […]

Dr Reddy’s sells Jeedimetla API plant to Therapiva

Dr. Reddy’s Laboratories, one of the biggest pharmaceutical companies in India, said it has agreed to sell its API manufacturing unit located in Jeedimetla, Hyderabad, to Therapiva Private Ltd, an emerging generics pharmaceutical company. The company did not reveal the financial details of the deal, but said the transaction is designed as a slump sale […]

USFDA approves Dr Reddy Lab’s UK plant after seven-month scrutiny

The United States Food & Drugs Administration has closed its audit of the UK manufacturing plant of Dr Reddy’s Laboratories, the Indian pharmaceutical company said. In September last year, the company had announced that the US FDA issued a Form 483 with three observations regarding operations at the pharmaceutical drug manufacturing plant at Mirfield, leading […]

Dr Reddy’s launches generic chemotherapy drug in the US

Pharma manufacturer Dr. Reddy’s Laboratories said it launched a generic version of chemotherapy drug drug Alkeran. The drug is used for palliative — or relief-oriented — treatment of multiple myeloma and epithelial carcinoma of the ovary. The Alkeran brand and generic had U.S. sales of approximately $107 million MAT for the most recent twelve months […]

Dr Reddy’s says EU approves production at Duvvada plant in Andhra

Pharma major Dr Reddy’s Laboratories said European Union authorities have again allowed it to produce drugs for sale in the EU region at its Duvvada factory in Andhra Pradesh. In its inspection conducted in September, the Regulatory Authority of Germany (Regierun von Oberbayern) had made six major observations on the formulations manufacturing facility near Vishakapattanam. […]

Dr Reddy’s gets served with class action lawsuit

Pharma major Dr Reddy’s Laboratories said it has been served with a class action lawsuit, originally announced in August, related to public disclosures made about regulatory action against the company. “Further to our intimation dated August 28, 2017 with regard to US Securities Class Action Lawsuit, we would like to inform you that the US […]

Dr Reddy’s hit by class action suit on “misleading statements” on FDA action

Pharma giant Dr Reddy’s Labs today said that a class action lawsuit has been filed against it on behalf of shareholders, alleging that the company misled investors causing them to lose money on their investments. “The lawsuit alleges that the company made materially false and/or misleading statements or omissions in connection with its corporate quality […]

Dr Reddy’s Labs launches osteoporosis drug in the US

Dr Reddy’s Laboratories Ltd said it launched raloxifene hydrochloride tablets –used to treat osteoporosis — in the US market. Raloxifene hydrochloride tablets are a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets. A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and […]

Dr Reddy’s Laboratories launches Paricalcitol injection in the US Market

Dr. Reddy’s Laboratories Ltd said it launched Paricalcitol Injection, a therapeutic equivalent generic version of Zemplar injection in the United States market approved by the US Food & Drug Administration (USFDA). The Zemplar brand and generic had US sales of approximately $22.5 million for the most recent twelve months ending in July 2016 according to […]

Dr. Reddy’s Laboratories launches heart drug in the US

Pharma company Dr. Reddy’s Laboratories Ltd said it launched Nitroglycerin sublingual tablets — a therapeutic equivalent generic version of Nitrostat sublingual tablets — in the US market. The medication is used before physical activities (such as exercise, sexual activity) to prevent chest pain (angina) in people with a certain heart condition (coronary artery disease). It may […]